Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in CERS — Cerus Corp

CIK 1390777 NEW YORK, NY
Back to CERS Full portfolio

Position in CERS

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$1,634,713
+$711,146 QoQ
Shares Held
559,834
+10.3% QoQ
Ownership
0.278%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 186 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 86% Shared 0% None 14%

Common Shares in CERS Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $5,939,407,538 across 81 Medical Devices names. CERS ranks #50 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EW
Edwards Lifesciences Corp
 14,084,483 $1,274,082,319
2 MDT
Medtronic plc
 14,694,253 $1,149,531,398
3 SYK
Stryker Corp
 3,548,516 $1,117,214,769
4 ABT
Abbott Laboratories
 9,991,899 $906,664,905
5 BSX
Boston Scientific Corp
 7,943,553 $339,030,832
6 GEHC
GE HealthCare Technologies Inc.
 2,639,900 $168,979,991
7 DXCM
Dexcom Inc
 2,309,648 $155,554,782
8 STE
STERIS plc
 503,402 $106,001,351

All Filings in CERS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,634,713 559,834
2026-03-31 $923,567 507,455
2025-12-31 $1,034,305 502,090
2025-09-30 $835,248 525,314
2025-06-30 $687,571 487,640
2025-03-31 $663,689 477,475
2024-12-31 $748,125 485,797
2024-09-30 $835,331 480,076
2024-06-30 $1,081,423 614,446
2024-03-31 $1,053,434 557,373
2023-12-31 $1,339,765 620,262
2023-09-30 $1,122,114 692,664
2023-06-30 $1,713,293 696,461
2023-03-31 $1,899,649 639,613
2022-12-31 $2,372,743 650,067
2022-09-30 $2,274,864 631,907
2022-06-30 $3,054,512 577,413
2022-03-31 $3,229,612 588,272
2021-12-31 $3,947,375 579,644
2021-09-30 $3,489,411 572,974
2021-06-30 $3,240,564 548,319
2021-03-31 $4,033,033 671,054
2020-12-31 $4,850,233 700,901
2020-09-30 $4,431,860 707,965
2020-06-30 $4,750,178 719,724
2020-03-31 $3,054,649 656,914